Covrprice Top 10 List for 9/19/19

Since Covrprice.com  came on the scene, they have become a go to spot for watching eBaytrends on comics. They scour thousands of eBay sales to cultivate data to spotlight the hottest selling comics. Here is this week’s Top Ten Comics: (Please note, potential spoilers do follow, and, these results are for auction that closed last week. )

1. YOUNG AVENGERS #1

Units Sold: 58
Raw Average: $59.83
Graded Average: $245 (9.8)
Reason: First appearance of Young Avengers

2. SPAWN #300 50 COPY INCV MCFARLANE VIRGIN

Units Sold: 50
Raw Average: $65
Graded Average: NA
Reason: 1:50 Variant for anniversary issue.

3. ABSOLUTE CARNAGE VS DEADPOOL #2 CODEX VARIANT

Units Sold: 23
Raw Average: $27.32
Graded Average: NA
Reason: Variant cover for hot series

4. SOMETHING IS KILLING THE CHILDREN #1 CVR A

Units Sold: 36
Raw Average: $8.65
Graded Average: NA
Reason: Hot new book

5. BLOODSHOT #37

Units Sold: 17
Raw Average: $23.33
Graded Average: NA
Reason: First Appearance Papa Juju. Movie option.

6. SOMETHING IS KILLING THE CHILDREN #1 Frison Variant

Units Sold: 32
Raw Average: $14.58
Graded Average: NA
Reason: Jenny Frison variant for hot new book

7. INFAMOUS IRON MAN #1

Units Sold: 13
Raw Average: $8.78
Graded Average: $56.17 (9.8)
Reason: First Appearance Tony Stark AI

8. HARBINGER #1

Units Sold: 23
Raw Average: $87.50
Graded Average: $188.00  (9.4, 9.8 recently sold for $730)
Reason: Recently optioned for movie

9. UNDISCOVERED COUNTRY Ashcan

Units Sold: 16
Raw Average: $74.75
Graded Average: NA
Reason: SDCC Ashacan for new Image optioned book

10. BATWING #19

Units Sold: 36
Raw Average: $42.49
Graded Average: NA
Reason: First appearance Luke Fox

Runners-up to follow.

One thought on “Covrprice Top 10 List for 9/19/19”

  1. batwing is amazing been buying them up like crazy don’t forget books like batman inc #5&batman beyond unlimited #2 anything batman beyond should not be forgotten as I belive the c.w. might spin a batman beyond show out of the crisis love you all blind adam out

Comments are closed.